SNY — Sanofi Aventis
In 2026 Q2, 7 of the 140 tracked hedge funds reported a position in Sanofi Aventis (SNY), worth $43.85M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| VanEck | $37.41M | 0.02% | -32.4% |
| Quadrature | $2.56M | 0.02% | NO CHANGE |
| Augustine | $1.88M | 0.38% | -1.9% |
| IMC | $933.14K | 0.00% | NEW |
| Persistent | $629.24K | 0.20% | +48.3% |
| Ping | $426.60K | 0.14% | NO CHANGE |
| Essex | $8.53K | 0.00% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.